In a plot twist absolutely nobody had on their political bingo card, FDA Commissioner Marty Makary is out of a job - and flavored vapes reportedly played a starring role in his downfall. Yes, really.
According to Vox's The Logoff, Makary, who led the federal agency responsible for regulating drugs and food, has resigned from his post. The exit follows a rocky tenure that apparently included friction over how the agency handled flavored vaping products - the same candy-colored, fruit-scented contraptions that have been the subject of regulatory battles for years.
So what actually went wrong?
The FDA commissionership is one of those jobs that sounds boring until you realize it touches almost everything Americans put in their bodies. Vapes, medications, food safety - it's all under that umbrella. And in an administration where seemingly every policy decision is three plot twists deep, even the guy running drug approvals couldn't escape the chaos.
The flavored vape issue is a particularly spicy one (strawberry-flavored, perhaps) because it sits at the intersection of public health concerns, Big Tobacco lobbying, and the perennial political question of whether the government should tell adults what they're allowed to enjoy. Regulators have been going back and forth on flavored vaping products for years, with critics arguing that sweet flavors specifically target younger users.
Why this actually matters
Look, it's easy to see "FDA chief resigns" and mentally file it under "Washington drama, not my problem." But the FDA is genuinely one of the most consequential agencies in the federal government. It decides what drugs get approved, what's considered safe to eat, and yes - what nicotine products land on convenience store shelves.
Leadership instability at the top of an agency like this doesn't just make for good headlines. It creates real uncertainty for the scientists, regulators, and public health professionals trying to do their jobs. Every time a commissioner exits under messy circumstances, ongoing decisions - including ones affecting things like medication approvals - get stuck in limbo.
Makary's departure is the latest in a string of high-profile exits from federal health agencies, and it raises the very reasonable question of who exactly wants to run the FDA right now, and under what conditions.
The vapes, though. Nobody could have predicted the vapes would be the thing. 2025 remains undefeated.
